{
    "code": 0,
    "data": [
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call of Orchid Pharma Limited for the Quarter-3 ended on December 31 2025.",
            "news_id": "0977b86c-b647-485f-b3f5-aa1e8dcf9fe6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fdc72b0-91a1-4189-bbc2-24c2d64cec2a.pdf",
            "news_date": "2026-02-12 18:32:19",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call of Orchid Pharma Limited for the Quarter-3 ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fdc72b0-91a1-4189-bbc2-24c2d64cec2a.pdf",
            "news_date": "2026-02-12 18:32:19"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for Quarter-III Ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19088348-19c7-42c4-9d79-b030d4bf5b16.pdf",
            "news_date": "2026-02-11 19:34:30"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Quarter III ended on December 31 2025.",
            "news_id": "b76a846b-2f32-47a8-8d18-cf26d0c4c9d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a21b328-f927-43c9-83cb-c1112f37bf04.pdf",
            "news_date": "2026-02-11 19:28:30",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Quarter III ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a21b328-f927-43c9-83cb-c1112f37bf04.pdf",
            "news_date": "2026-02-11 19:28:30"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Unaudited Limited Review Standalone & Consolidated Financial Results For The Quarter And Year To Date Ended On December 31 2025",
            "news_body": "Unaudited limited review Standalone & Consolidated Financial Results for the quarter and year to date ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07cb1609-fd61-4fae-8f84-c5af45a7efa5.pdf",
            "news_date": "2026-02-11 17:48:43"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quarterly Results",
            "news_body": "Unaudited limited reviewed Standalone & Consolidated Financial Results of the Company for the quarter and year to date period ended on December 31 2025.",
            "news_id": "371e5039-a2c6-4946-93de-adcb8e737582",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7296e13a-19e7-4b8d-8f4f-d497f8f722a0.pdf",
            "news_date": "2026-02-11 17:43:57",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Quarterly Results",
            "news_body": "Unaudited limited reviewed Standalone & Consolidated Financial Results of the Company for the quarter and year to date period ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7296e13a-19e7-4b8d-8f4f-d497f8f722a0.pdf",
            "news_date": "2026-02-11 17:43:57"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analysts/ Investors Earning Call ratifying the inadvertent display error in earlier communication scheduling the meet for the quarter III of financial year 2025-26 ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88c581f8-f69e-4bdc-9c46-79dd8c34fd47.pdf",
            "news_date": "2026-02-06 16:08:44"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-III of F.Y. 2025-26 ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c243c94-7e58-4f6e-8206-e266247c0652.pdf",
            "news_date": "2026-02-06 15:26:57"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for The Quarter-III Of Financial Year 2025-26 Ended On December 2025.",
            "news_body": "Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-III of Financial Year 2025-26 ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94fa843b-64ea-45f3-8a68-498987b2c875.pdf",
            "news_date": "2026-02-06 14:37:43"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance certificate under regulation 74(5) of SEBI (Depositories and participants) Regulations for the Quarter-III of F.Y. 2025-26 ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a34d75a-4fc3-4c04-94da-f5a0c5186c7c.pdf",
            "news_date": "2026-01-08 16:33:32"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure for the Quarter III of Financial Year 2025-26 ending on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be3dbb62-50a0-4ccc-91e0-555b06c072de.pdf",
            "news_date": "2025-12-29 18:15:51"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analysts/ Investors Earning call held with public at large on November 11 2025 for the quarter ended September 2025",
            "news_id": "f42da8ce-5887-4af6-94c8-9d0d412c32b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4424c13c-8f23-49e1-b630-4d5464d9f240.pdf",
            "news_date": "2025-11-17 16:05:26",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analysts/ Investors Earning call held with public at large on November 11 2025 for the quarter ended September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4424c13c-8f23-49e1-b630-4d5464d9f240.pdf",
            "news_date": "2025-11-17 16:05:26"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the Quarter-2 of F.Y. 2025-26 ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea690b7d-eb31-46f9-9462-bbfc224c1088.pdf",
            "news_date": "2025-11-13 13:13:51"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Earnings call for the Financial Results of the Company for the Q-2 & Half year ended on September 30 2025.",
            "news_id": "31cbd9bf-7dee-471d-ae2d-56e35f82f027",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8416c4-c432-4e44-bf69-63627f93f764.pdf",
            "news_date": "2025-11-11 19:23:22",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Earnings call for the Financial Results of the Company for the Q-2 & Half year ended on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8416c4-c432-4e44-bf69-63627f93f764.pdf",
            "news_date": "2025-11-11 19:23:22"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Analysts/Investors Earnings Call for the Q-2 & Half Year for F.Y.2025-26 ended on September 30 2025.",
            "news_id": "1612b59d-96be-4b94-b5cf-eb6f28971d0c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d207b0b0-043d-4d16-b3d5-57a929c180cd.pdf",
            "news_date": "2025-11-11 15:37:21",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Analysts/Investors Earnings Call for the Q-2 & Half Year for F.Y.2025-26 ended on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d207b0b0-043d-4d16-b3d5-57a929c180cd.pdf",
            "news_date": "2025-11-11 15:37:21"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Limited Reviewed Financial Results For Q-2 Of F.Y.2025-26",
            "news_body": "Unaudited Limited Reviewed Financial Results for the Q-2 & Half Year ended on September 30 2025",
            "news_id": "92f7d760-954a-4353-856d-573a3098f445",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e8feff4-1fe0-4fc1-9d32-faa9109a5f68.pdf",
            "news_date": "2025-11-11 15:28:09",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Limited Reviewed Financial Results For Q-2 Of F.Y.2025-26",
            "news_body": "Unaudited Limited Reviewed Financial Results for the Q-2 & Half Year ended on September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e8feff4-1fe0-4fc1-9d32-faa9109a5f68.pdf",
            "news_date": "2025-11-11 15:28:09"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting- Q2- F.Y.2025-26",
            "news_body": "Outcome of Board Meeting- Q2- F.Y.2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fe004e6-eba9-4aa9-bd9f-c321910426e8.pdf",
            "news_date": "2025-11-11 15:21:52"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-II of F.Y. 2025-26 ended on September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c8ba36b-4aa0-4a1e-ba48-f96f68943657.pdf",
            "news_date": "2025-11-05 14:47:37"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On November 11 2025\r\n",
            "news_body": "Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Prior Intimation of Board Meeting scheduled to be held on November 11 2025 for approving Unaudited Limited Reviewed Financial Results for Quarter II and half year for Financial Year 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b87e4c2d-412f-43eb-b191-270841c4057f.pdf",
            "news_date": "2025-11-05 12:20:15"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Company Response On The Spurt In Volume Of Security Across Exchanges",
            "news_body": "Orchid Pharma Limiteds response on the spurt in volume of security across stock exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60932ba0-2c9b-453d-86dd-95996f7177d3.pdf",
            "news_date": "2025-11-04 12:36:04"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Orchid Pharma Ltd",
            "news_body": "The Exchange has sought clarification from Orchid Pharma Ltd on November 04 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-11-04 11:19:38"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Purchase Of Assets Of Allecra Therapeutics Gmbh",
            "news_body": "Intimation of completion of purchase of Assets of Allecra Therapeutics GmbH",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a17351a-29f1-4491-ac9f-f8e6b135c869.pdf",
            "news_date": "2025-10-30 17:17:49"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 for the quarter-II of F.Y.2025-26 ended on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6022223c-2727-4a84-96bb-aba8358b2daa.pdf",
            "news_date": "2025-10-10 17:12:16"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure for considering and approving Unaudited Limited Reviewed Financial Results for the Quarter- II of F.Y. 2025-26 ending on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c3345d2-1c2f-4cde-9847-098ee9422e38.pdf",
            "news_date": "2025-09-29 17:58:40"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Scrutinizers Report including Voting Results for the Annual General Meeting of Orchid Pharma Limited held on September 20 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a1a0aaf-1429-4ad0-a248-49379482f1a4.pdf",
            "news_date": "2025-09-22 18:14:24"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Meeting Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
            "news_body": "Proceedings of 32nd Annual General Meeting of Orchid Pharma Limited held on September 20 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07151fc4-c952-44e0-8344-3301bc1b268f.pdf",
            "news_date": "2025-09-20 17:39:59"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of 32nd Annual General Meeting of Orchid Pharma Limited held on September 20 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=529b7e39-a777-4a59-bf0d-0f94e7fbf619.pdf",
            "news_date": "2025-09-20 17:25:11"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Corrigendum To Notice Of 32Nd Annual General Meeting Of Orchid Pharma Limited (The Company) For The F.Y. 2024-25",
            "news_body": "Corrigendum to Notice of 32nd Annual General meeting of Orchid Pharma Limited (the Company) for the F.Y. 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6f1daf4-0052-4d50-83a7-f93ba58d2d76.pdf",
            "news_date": "2025-09-10 19:00:57"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "CORRIGENDUM TO NOTICE OF 32ND ANNUAL GENERAL MEETING",
            "news_body": "Corrigendum to Notice of 32nd Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b8ee948-ebb4-4cb6-907e-8e76d396fb40.pdf",
            "news_date": "2025-09-10 18:30:36"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited ( Amalgamating Company ) With Orchid Pharma Limited ( Amalgamated Company/Company )",
            "news_body": "Intimation related to the Scheme of Amalgamtion of Dhanuka Laboratories Limited with Orchid Pharma Limited and their respective shareholders and creditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10d363d9-f217-499d-a1c9-76ed1e79af04.pdf",
            "news_date": "2025-08-29 18:55:04"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Notice of AGM scheduled to be held on September 20 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3140034-0e8e-40ae-8267-76081506c6b5.pdf",
            "news_date": "2025-08-27 19:20:35"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report of the Company for the F.Y.2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed82e477-40ea-409f-ab81-3bf7d69908ae.pdf",
            "news_date": "2025-08-27 00:18:33"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report of the Company for the F.Y.2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0642cbc-43b9-4e32-80ed-e6f09a8c984b.pdf",
            "news_date": "2025-08-26 22:05:05"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Annual Report And Notice Of 32Nd Annual General Meeting Of Orchid Pharma Limited (The Company) For The F.Y. 2024-25",
            "news_body": "Intimation of Annual Report and Notice of 32nd Annual General Meeting of the Company for the F.Y.2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9349c2ae-e631-47e5-a831-45521f95535b.pdf",
            "news_date": "2025-08-26 21:49:45"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst / Investors earning call held with public at large on 12th August 2025- Orchid Pharma Limited.",
            "news_id": "0687a381-23d8-400e-ba51-8e36b43fcf6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fae146e7-56e5-4373-9698-6e93c752fd5c.pdf",
            "news_date": "2025-08-14 17:07:42",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst / Investors earning call held with public at large on 12th August 2025- Orchid Pharma Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fae146e7-56e5-4373-9698-6e93c752fd5c.pdf",
            "news_date": "2025-08-14 17:07:42"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Investor meet Scheduled to be held on August 20 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0f1d582-2408-451a-bb85-3e97356049aa.pdf",
            "news_date": "2025-08-13 16:12:49"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Intimation of Audio Recording of the Investors/Earnings call for the Q-1 of F.Y.2025-26 ended June 30 2025.",
            "news_id": "b7d64188-2d9a-4729-a09f-12fba87258d3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5974295d-425e-4088-a9e9-7c76f1902162.pdf",
            "news_date": "2025-08-12 19:49:55",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Intimation of Audio Recording of the Investors/Earnings call for the Q-1 of F.Y.2025-26 ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5974295d-425e-4088-a9e9-7c76f1902162.pdf",
            "news_date": "2025-08-12 19:49:55"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report of the Company for the Q-1 of F.Y.2025-26 ended on June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b7c2e4f-c660-4d2c-81ca-08a546dad9c3.pdf",
            "news_date": "2025-08-12 16:40:11"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Intimation Of Appointment Of Auditors Of The Company",
            "news_body": "Intimation of appointment of Secretarial Cost and Internal Auditors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1f31e05-2c74-4e75-abc0-71581005a217.pdf",
            "news_date": "2025-08-12 16:16:31"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Investor Presentation for the financial results of Q-1 of F.Y.25-26",
            "news_id": "615608d0-6b8b-4d25-9d2b-9f74977c339f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e356cbc-55b6-49b8-8e6b-a336760bb3e6.pdf",
            "news_date": "2025-08-12 16:08:42",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Investor Presentation for the financial results of Q-1 of F.Y.25-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e356cbc-55b6-49b8-8e6b-a336760bb3e6.pdf",
            "news_date": "2025-08-12 16:08:42"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Inter-Alia For Consideration And Approval Of Financial Results For The Q-1 Of F.Y.2025-26 Ended On June 30 2025",
            "news_body": "Outcome of Board Meeting inter-alia for consideration and approval of Financial Results for the Q-1 of F.Y.2025-26 ended on June 30 2025.",
            "news_id": "3e48d2a1-815b-4282-9fe7-bca460f6c912",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab6569cb-597c-4a53-9317-d573b934fdd2.pdf",
            "news_date": "2025-08-12 15:57:06",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting Inter-Alia For Consideration And Approval Of Financial Results For The Q-1 Of F.Y.2025-26 Ended On June 30 2025",
            "news_body": "Outcome of Board Meeting inter-alia for consideration and approval of Financial Results for the Q-1 of F.Y.2025-26 ended on June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab6569cb-597c-4a53-9317-d573b934fdd2.pdf",
            "news_date": "2025-08-12 15:57:06"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting inter-alia for consideration and approval of Financial Results for the Q-1 of F.Y. 2025-26 ended on June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27d4c57e-cb97-4cf3-b72f-4441fab68a60.pdf",
            "news_date": "2025-08-12 15:43:35"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-I of F.Y. 2025-26 ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ebe6152-4a4a-4acb-8555-2cb2036ec889.pdf",
            "news_date": "2025-08-07 17:18:38"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Review of Credit Ratings - Orchid Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8767610-cec8-4724-9d99-fc3bbd365a04.pdf",
            "news_date": "2025-08-07 16:48:45"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Purchase Of Assets Of Allecra Therapeutics SAS",
            "news_body": "Update on the purchase of assets of Allecra Therapeutics SAS in france.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f30c06c-a715-4b90-a0f5-588cf6390164.pdf",
            "news_date": "2025-08-05 21:31:44"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) Of The Company For Quarter-1 Of F.Y.2025-26",
            "news_body": "Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve approval of Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for Quarter-1 of F.Y.2025-26 ended on June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72a5a7b0-39d1-4ce4-94ff-ff0203052812.pdf",
            "news_date": "2025-08-05 17:50:35"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Purchase Of Assets Of Allecra Therapeutics Gmbh\r\nAnd Allecra Therapeutics SAS Related To Enmetazobactam.",
            "news_body": "Purchase of assets of Allecra Therapeutics GmbH and Allecra Therapeutics SAS related to Enmetazobatam",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2869b69-e423-4daa-8077-b7e01614552a.pdf",
            "news_date": "2025-07-30 20:11:55"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Disclosure regarding acquisition of Weilchensee 1272. V V GmbH a foreign Company with limited liability",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4f08ebc-df1a-4f17-9013-31ef3a81d84a.pdf",
            "news_date": "2025-07-30 19:59:37"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Execution Of Deed Of Hypothecation In Favour Of HDFC Bank Limited",
            "news_body": "Intimation for execution of Deed of Hypothecation in favour of HDFC Bank Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=baf02a44-298a-43ce-a9e2-5b7438566a9a.pdf",
            "news_date": "2025-07-17 18:25:57"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (Depositories Participants) Regulation 2018 as amended for Quarter-I of F.Y. 2025-26 ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0618adb1-170a-4854-98fd-af1796285089.pdf",
            "news_date": "2025-07-14 16:58:17"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Related To The Scheme Of Amalgamation Of Dhanuka\r\nLaboratories Limited (Amalgamating Company) With Orchid Pharma Limited (Amalgamated Company/Company) And Their Respective Shareholders And Creditors (The Scheme) Under Regulation 30 Of SEBI (Lis",
            "news_body": "Intimation of filing second motion petition related to the Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited and their respective Shareholders and Creditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=890cb9b4-6bc4-465b-940b-64e33bd9b293.pdf",
            "news_date": "2025-07-10 16:24:12"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Court Convened Meeting",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Voting Results along-with the Scrutinizer Report for the Honble NCLT convened Meeting of Equity Shareholders held on June 26 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e6a7642-3fd6-44b2-abe6-c086a8cdeabe.pdf",
            "news_date": "2025-06-30 19:09:59"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation for re-appointment of Independent Directors of Orchid Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99981fad-3707-40ec-8f39-82a5de0acb09.pdf",
            "news_date": "2025-06-30 19:01:59"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading window for the Quarter-1 of F.Y.2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=254b961b-b8cd-41ef-890c-0fc85cb097f4.pdf",
            "news_date": "2025-06-26 17:40:09"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Court Convened Meeting",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting",
            "news_body": "Summary Proceedings of Honble NCLT convened meeting of Equity Shareholders of Orchid Pharma Limited to consider and approve the Scheme of Merger of Dhanuka Laboratories Limited with the Company and their respective shareholders and creditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=668c73e9-e9af-48b5-9261-754808051880.pdf",
            "news_date": "2025-06-26 17:36:08"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date For Voting Rights Of Shareholders W.R.T. The Meeting Of Equity Shareholders Of Orchid Pharma Limited (\"Company\"/ \"Amalgamated Company\") Convened Pursuant To The Order Passed By Honble National Company Law Tribunal For Considering",
            "news_body": "Intimation of Record date for voting rights of shareholders w.r.t. the meeting of equity shareholders of Orchid Pharma Limited (\"Company\"/ \"Amalgamated Company\") convened pursuant to the order passed by Honble National Company Law Tribunal for considering and approving the Scheme of amalgamation of the Dhanuka Laboratories Limited (\"Amalgamating Company\") with the Company and their respective shareholders and creditors (\"the Scheme\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c68c83d2-bce4-4efa-8e38-128394e490ef.pdf",
            "news_date": "2025-06-09 18:47:06"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI Listing Regulations- Honble National Company Law Tribunal Order To Dispose-Off Dispute On Lease Rentals With DBS Bank India Limited.",
            "news_body": "Honble National Company Law Tribunal order to dispose off dispute on lease rentals with DBS Bank Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fa8306e-740c-417e-a486-cb990a3fa874.pdf",
            "news_date": "2025-06-06 19:09:15"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Of Corporate Guarantee On Behalf Of Orchid Bio-Pharma Limited (Wholly Owned Subsidiary)",
            "news_body": "Disclosure of Corporate Guarantee on behalf of Orchid Bio-Pharma Limited (Wholly Owned Subsidiary)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce85fd73-4a7c-4891-91d7-605d631b7609.pdf",
            "news_date": "2025-06-03 13:27:10"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst/ Investor Earning Call held with public at large on May 26 2025 on financial performance/ financial results for the Quarter-IV and Financial Year ended on March 31 2025.",
            "news_id": "87f89c81-1314-4ac7-9b72-75ff34715d48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcf5f67e-4d5b-4737-90a6-03c6644f124a.pdf",
            "news_date": "2025-06-02 17:21:48",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst/ Investor Earning Call held with public at large on May 26 2025 on financial performance/ financial results for the Quarter-IV and Financial Year ended on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcf5f67e-4d5b-4737-90a6-03c6644f124a.pdf",
            "news_date": "2025-06-02 17:21:48"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation On Receipt Of EIR After The USFDA Inspection At The Plant Of The Company Situated At Alathur",
            "news_body": "Intimation on receipt of EIR after the USFDA inspection at the plant of the company situated at Alathur",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ecb10da-bedb-4361-8de8-7000b5afbc1c.pdf",
            "news_date": "2025-05-29 17:50:15"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Board Comments On Fine Levied By The Exchange",
            "news_body": "Board Comments on fine levied by the Exchange",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3efa3a51-c6d0-4404-ae59-14b52f88651a.pdf",
            "news_date": "2025-05-28 19:04:46"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report pursuant to Regulation 24A(2) of SEBI (LODR) Regulations 2015 as amended for Financial Year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29d8ded2-0e21-472c-9278-0a7772aaeff2.pdf",
            "news_date": "2025-05-28 18:48:49"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (the Company)",
            "news_id": "3663ec85-956a-4d0b-b181-1df3552d1a34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48115633-c9d9-45f6-83e3-e1c4500f3cd6.pdf",
            "news_date": "2025-05-26 21:46:37",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (the Company)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48115633-c9d9-45f6-83e3-e1c4500f3cd6.pdf",
            "news_date": "2025-05-26 21:46:37"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of Newspaper Publication related to Advertisement of Notice of NCLT Convened meetings of Shareholders and Unsecured Creditors of Orchid Pharma Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3082f9a-8558-4e4f-9c37-5f298dc09dde.pdf",
            "news_date": "2025-05-26 21:07:12"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for quarterly and Annual Financial Results for the period ended on March 31 2025",
            "news_id": "2598a0b5-ec49-4ac8-b0c6-bf4f2635a4be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4636c79d-2779-45fd-90b0-bbb702ff8caa.pdf",
            "news_date": "2025-05-26 16:14:49",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for quarterly and Annual Financial Results for the period ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4636c79d-2779-45fd-90b0-bbb702ff8caa.pdf",
            "news_date": "2025-05-26 16:14:49"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Annual Audited Financial Results For The Quarter And F.Y. Ended On March 31 2025",
            "news_body": "Annual Audited Financial Results for the quarter and F.Y.2025",
            "news_id": "ca90cf4e-be3e-4fb4-aa6b-ba152e44e890",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01febc5e-06ff-4950-b96a-bc83e42d038a.pdf",
            "news_date": "2025-05-26 16:06:59",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Annual Audited Financial Results For The Quarter And F.Y. Ended On March 31 2025",
            "news_body": "Annual Audited Financial Results for the quarter and F.Y.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01febc5e-06ff-4950-b96a-bc83e42d038a.pdf",
            "news_date": "2025-05-26 16:06:59"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting For Considering And Approving Annual Audited Financial Results For The Quarter And F.Y. Ended On March 31 2025",
            "news_body": "Outcome of Board Meeting for considering and approving Annual Audited Financial Results for the quarter and F.Y. ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd7c5501-3cce-409c-86c4-918e85120c75.pdf",
            "news_date": "2025-05-26 15:54:58"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Court Convened Meeting",
            "caption": "Notice Of Meeting Of Equity Shareholders And Unsecured Creditors Of Orchid Pharma Ltd Convened Pursuant To The Order Passed By Honble National Company Law Tribunal",
            "news_body": "Notice of Meeting of Equity Shareholders and Unsecured Creditors of Orchid Pharma Ltd convened pursuant to the order passed by Honble National Company Law Tribunal for considering and approving the Scheme of Amalgamation of Dhanuka Laboratories Ltd with Orchid Pharma Ltd and their respective shareholders and creditors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3b330b2-2dfc-4fdc-80c6-31cbe32a10f3.pdf",
            "news_date": "2025-05-25 00:32:33"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-IV and Financial Year ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1823bca-65dd-47d5-8c89-ca16a1839f92.pdf",
            "news_date": "2025-05-20 18:39:55"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for The Board Meeting Scheduled To Be Held On May 26 2025",
            "news_body": "Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve the Audited Financial Results (Standalone & Consolidate) of the company for the Quarter-IV and Financial Year ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f53937f-0f48-471b-8979-c022b99c0706.pdf",
            "news_date": "2025-05-20 18:21:39"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency report for the Quarter-IV of Financial Year 2024-25 ended on March 31 2025 of Orchid Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=378641e1-b939-4cb1-94f4-0f0bcac704e5.pdf",
            "news_date": "2025-05-15 15:47:11"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (Amalgamating Company) With Orchid Pharma Limited (Company/ Amalgamated Company) And Their Respective Shareholders And Creditors (The Scheme) Under Regulation 30 Of SEBI (Lis",
            "news_body": "Intimation related to the Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited and their respective Shareholders and Creditors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a682ee94-fd17-49d3-ba4a-84df7d38a520.pdf",
            "news_date": "2025-05-13 19:24:48"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Read With Schedule III Of SEBI Listing Regulations",
            "news_body": "Intimation under Regulation 30 read with Schedule III of SEBI Listing Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f544a900-cf98-4168-85ed-cc2defde6336.pdf",
            "news_date": "2025-05-10 19:53:26"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation On Scheme Of Amalgamation Of Dhanuka Laboratories Limited (\"Amalgamating Company\") With Orchid Pharma Limited (\"Company\"/ \"Amalgamated Company\") And Their Respective Shareholders And Creditors.",
            "news_body": "Intimation on Scheme of Amalgamation of Dhanuka Laboratories Limited (\"Amalgamating Company\") with Orchid Pharma Limited (\"Company\"/\"Amalgamated Company\") and their respective shareholders and creditors under Regulation 30 SEBI Listing Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ad55ee8-8ef3-4572-adaf-a07632b2aee9.pdf",
            "news_date": "2025-05-03 16:45:25"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for Quarter IV of F.Y. 2024-25 ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d305391-4053-412e-9fe9-17c69cfda8bd.pdf",
            "news_date": "2025-04-11 11:34:24"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Memorandum of Understanding /Agreements",
            "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
            "news_body": "Intimation for entering into a Joint Memo of Compromise with DBS Bank India Limited under Regulation 30 of SEBI Listing Regulations.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f315f289-72e1-42ab-a6e3-b55c56f2473f.pdf",
            "news_date": "2025-04-09 17:28:02"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Letter(S)/Emails Received From Stock Exchanges As Cautionary Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation of Letters/emails received from Stock Exchanges as Cautionary under SEBI Listing Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6d03d06-6baf-4078-8a50-115d579597db.pdf",
            "news_date": "2025-03-29 15:33:01"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of the Trading Window Closure for the Quarter IV and Financial Year ending on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8b5e665-bf24-499d-8d99-8633ae89353e.pdf",
            "news_date": "2025-03-27 18:18:03"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30- Scheme Of Amalgamation Of Dhanuka Laboratories Limited (Amalgamating Company) With Orchid Pharma Limited (Company/ Amalgamated Company) And Their Respective Shareholders And Creditors",
            "news_body": "Update on Scheme of Amalgamation of Dhanuka Laboratories Limited (\"Amalgamating Company\") with Orchid Pharma Limited (\"Company\"/\"Amalgamated Company\") and their respective Shareholders and Creditors.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3ed01cd-a24f-4059-876f-607d6a9ecc71.pdf",
            "news_date": "2025-03-10 21:14:59"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Review of Credit Rating of Orchid Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=472933dc-db36-42b0-b7b3-4de72d013993.pdf",
            "news_date": "2025-03-07 13:04:44"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Regarding The Order Passed By Goods And Service Tax Department",
            "news_body": "Disclosure regarding the Order passed by Goods & Service Tax Department",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc801b2d-93d4-4509-a024-f8a4f31900c9.pdf",
            "news_date": "2025-02-28 16:29:27"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Orchid Pharmas Alathur API facility successfully completes USFDA Inspection maintaining its position as Indias only USFDA approved facility for Sterile Cephalosporins.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36b07a63-85c7-40c4-af2d-14e242a57625.pdf",
            "news_date": "2025-02-19 17:58:00"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst/ Investor earning call held with public at large on February 12 2025 for Financial Results of Quarter III of FY 2024-25 ended on December 31 2024- Orchid Pharma Limited",
            "news_id": "684d878f-4570-4446-a475-7a0426b1c6ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ba7c57c-42b0-4766-9e96-76f618bc6b91.pdf",
            "news_date": "2025-02-15 16:05:32",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst/ Investor earning call held with public at large on February 12 2025 for Financial Results of Quarter III of FY 2024-25 ended on December 31 2024- Orchid Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ba7c57c-42b0-4766-9e96-76f618bc6b91.pdf",
            "news_date": "2025-02-15 16:05:32"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call for Unaudited Financial results of Quarter III of F.Y. 2024-25 ended on December 31 2024 - Orchid Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1172f35e-775b-4cb1-9ea6-fbce767f4e02.pdf",
            "news_date": "2025-02-12 19:28:40"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release of Orchid Pharma titled as \"Orchid Pharma continues on a steady growth path with strengthening market position\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ed7adcf-659f-476d-8635-d4cb5cb59ae9.pdf",
            "news_date": "2025-02-12 18:31:32"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report of the Company for the Quarter-111 of F.Y.2024-25 ended on December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37593ecc-441c-47f4-bfd5-7b5ff98bd58b.pdf",
            "news_date": "2025-02-12 17:08:47"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation Or Variation For The Quarter-III Of F.Y.2024-25 Ended On December 31 2024.",
            "news_body": "Statement of Deviation or Variation for the Quarter-III of F.Y.2024-25 ended on December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ff3c07a-3c5a-47dc-b056-3f8b0ae48943.pdf",
            "news_date": "2025-02-12 17:00:16"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financial) for the Quarter-III of F.Y.2024-25 ended on December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25364f81-901e-416a-bf77-a2c6ea7390a6.pdf",
            "news_date": "2025-02-12 16:54:40"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Analysts/Earnings Call for Quarter-III of F.Y.2024-25 ended on December 31 2024.",
            "news_id": "e8af317d-e2e9-42c2-82d7-ace81a45f4d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a747e4a9-cd5b-43b3-8f2e-40c079aaaf9f.pdf",
            "news_date": "2025-02-12 15:55:39",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Analysts/Earnings Call for Quarter-III of F.Y.2024-25 ended on December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a747e4a9-cd5b-43b3-8f2e-40c079aaaf9f.pdf",
            "news_date": "2025-02-12 15:55:39"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held For Inter Alia Consideration And Approval Of Unaudited Limited Reviewed Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended On Decemb",
            "news_body": "Outcome of the Board Meeting including inter alia Financial Results for the quarter ended on December 31 2024.",
            "news_id": "bb4554c7-e5fd-4b39-aa6a-cfc2dce876d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43359b09-b28e-47da-96e3-a304163e4fff.pdf",
            "news_date": "2025-02-12 15:42:07",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held For Inter Alia Consideration And Approval Of Unaudited Limited Reviewed Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended On Decemb",
            "news_body": "Outcome of the Board Meeting including inter alia Financial Results for the quarter ended on December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43359b09-b28e-47da-96e3-a304163e4fff.pdf",
            "news_date": "2025-02-12 15:42:07"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board meeting held for inter alia consideration and approval of Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) for the Quarter ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5935345-1ef9-4674-b716-38d4578a4033.pdf",
            "news_date": "2025-02-12 15:35:38"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-III of F.Y.2024-25 ended on December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd82bfd7-534c-4415-a5c4-a1b1f1d27015.pdf",
            "news_date": "2025-02-06 18:13:25"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On February 12 2025",
            "news_body": "Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the un-audited Limited Reviewed Financial Results for the Quarter III of Financial Year 2024-25 ended on December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c607fe57-3b44-4406-a7df-abb98bd21d62.pdf",
            "news_date": "2025-02-06 18:00:15"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under regulation 74(5) Securities and Exchange Board of India (Depository and Participants) Regulations 2018 as amended",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5f43e65-ba48-40b2-b30f-a3a686ccc311.pdf",
            "news_date": "2025-01-13 18:26:13"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure for the Quarter-III of F.Y.2024-25 ending on December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d78123be-377d-4fd4-a34c-d728efd54211.pdf",
            "news_date": "2024-12-30 17:50:22"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Analysts/Investors Earning Call held on November 11, 2024 on the Financial Performance of the Company for the Quarter and Half Year ended on September 30, 2024.",
            "news_id": "b4987802-972a-4ed6-b6cf-f757a859e2fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd7ca577-5c5b-4336-b529-f3dc78144921.pdf",
            "news_date": "2024-11-15 13:10:42",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Company Update",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Analysts/Investors Earning Call held on November 11, 2024 on the Financial Performance of the Company for the Quarter and Half Year ended on September 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd7ca577-5c5b-4336-b529-f3dc78144921.pdf",
            "news_date": "2024-11-15 13:10:42"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Newspaper Publication Of Unaudited Limited ReviewedFinancial Results (Standalone & Consolidated) For Quarter- II And Half Year Ended On September 30, 2024 Of Financial Year 2024-25",
            "news_body": "Newspaper Publication of Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of Orchid Pharma Limited for Quarter- II and Half Year ended on September 30, 2024 of Financial Year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94a0a8dc-ebab-4d7d-86d7-8a0a573266e1.pdf",
            "news_date": "2024-11-12 16:00:15"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call held on November 11, 2024",
            "news_id": "6a5cec52-a770-466b-a81d-be9e155d19d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbb6e04e-8096-481c-9de5-b591e1bae79a.pdf",
            "news_date": "2024-11-11 18:55:28",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call held on November 11, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbb6e04e-8096-481c-9de5-b591e1bae79a.pdf",
            "news_date": "2024-11-11 18:55:28"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Company Update",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release- Orchid Pharma reports strong Q2 performance driven by new product milestones",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e7cc376-9479-4f3d-8261-f2fa19635b48.pdf",
            "news_date": "2024-11-11 18:31:01"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Company Update",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the Quarter-II of the Financial Year 2024-25, ended on September 30, 2024, of Orchid Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85a73ce9-4076-4668-bd99-fba82d6707f4.pdf",
            "news_date": "2024-11-11 18:11:02"
        },
        {
            "co_code": 3135,
            "bse_code": 524372,
            "isin": "INE191A01027",
            "ann_type": "Company Update",
            "descriptor": "Reg. 32 (1), (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation Or Variation For The Quarter Ended On September 30, 2024",
            "news_body": "Statement of Deviation or Variation for the Quarter ended on September 30, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39979a37-8689-4269-9847-242ad68db53a.pdf",
            "news_date": "2024-11-11 15:41:27"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Earnings/Investors Calls scheduled to be held on November 11, 2024",
            "news_id": "ee7cf212-0103-4e3f-a41a-fb6073a12000",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=973e25de-97c7-444b-a731-5642d7e8bfc2.pdf",
            "news_date": "2024-11-11 15:32:05",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2024",
            "news_body": "Unaudited Financial Results for the Quarter and Half Year ended on September 30, 2024",
            "news_id": "30f4d116-7926-4c0e-a78e-c478df15f1e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d86b0ab-48fa-4fbc-b14a-f3ff9f954160.pdf",
            "news_date": "2024-11-11 15:10:22",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analysts/ Investors Earning Call for the Financial Results of the Company for the Quarter- 1 of Financial Year 2024-25, ended on June 30, 2024.",
            "news_id": "4782480b-acb9-4fe5-971a-6f029d24e4da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99977bd2-71eb-493d-a563-5b112ac1b2f0.pdf",
            "news_date": "2024-08-17 19:00:54",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call of Orchid Pharma Limited for the Financial Results of Quarter-1 of Financial Year-2024-25, ended on June 30, 2024",
            "news_id": "500ad0b5-61e7-4eb5-bd17-04a7dafdb95e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fcf20b9-942d-4494-a040-32d997bd8e2c.pdf",
            "news_date": "2024-08-13 20:13:08",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Analysts/ Earnings Call for Quarter-1 of F.Y.2024-25, ended on June 30, 2024",
            "news_id": "b1ddbd37-0b4f-4062-aa23-0b08e9cc07ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ab4b5c0-26de-4869-ba25-fd58974cebed.pdf",
            "news_date": "2024-08-13 14:54:53",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Qtr June 2024",
            "news_body": "Financial Results for the quarter ended June 2024",
            "news_id": "39fb8502-b387-4254-8288-3c7b53c40a43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01292b1b-b156-42ba-9183-e2f424bd62ff.pdf",
            "news_date": "2024-08-12 19:29:20",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for the Investor/Analysts Earnings Call held on May 24, 2024.",
            "news_id": "edc3b9ba-51cb-470d-8502-197502ad18cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b22861ec-3c50-416e-897d-97aa40d2498d.pdf",
            "news_date": "2024-05-29 17:54:43",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call held today i.e. May 24, 2024 at 04:00 P.M. (IST) to discuss the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended on March 31, 2024.",
            "news_id": "b82a94e2-b2e5-452d-88f9-f897040184a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83cf7263-544d-40b0-bbea-655e9b257477.pdf",
            "news_date": "2024-05-24 20:49:36",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4- Financial Year 2023-24",
            "news_id": "992c0bc4-d1d3-4245-8e2c-231c03dbba59",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa33e2d1-2388-4fb0-9240-54ebf4b6ebaa.pdf",
            "news_date": "2024-05-23 21:56:16",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For Financial Year Ended On March 31, 2024",
            "news_body": "Audited Financial Results along with Auditor''s Report for Financial Year ended on March 31, 2024",
            "news_id": "75466cf2-7482-4f23-922a-80b45e72d1bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31a6c667-0f71-41f3-ab03-0fe76460765b.pdf",
            "news_date": "2024-05-23 20:17:04",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Earning Call Transcript",
            "news_id": "26f93800-45f9-439b-ab5d-8fa820aec07c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31053f17-cf09-4489-985d-aec06571372c.pdf",
            "news_date": "2024-02-13 17:50:14",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the Investor Presentation on the financial highlights of the Company w.r.t the quarter ended on December 31, 2023.",
            "news_id": "7918bc04-caf3-4aa4-81c6-79df1d718430",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02cc107a-d794-4d31-8259-28892be8a3f6.pdf",
            "news_date": "2024-02-08 23:28:24",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For Quarter Ended On December 31, 2023",
            "news_body": "Financial Results for the Quarter ended on December 31, 2023",
            "news_id": "57bfe0af-851e-42b1-9dda-efb0a80a3e5a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86596dc6-c5b4-45fc-9044-c65291cf7e87.pdf",
            "news_date": "2024-02-08 15:54:18",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Investor Meeting and Road Show",
            "news_id": "bc64a0a9-e2e2-4e4a-85d5-0e9b6d5d42e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86ab5d16-c66f-4fcd-a862-71fa226867ef.pdf",
            "news_date": "2023-11-20 17:11:56",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Announcement under Regulation 30 (LODR) - Earning Call Transcript",
            "news_id": "87a51fd2-b6ab-458f-9176-24fce9d34ba8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57960835-3b34-44c1-bffc-ff6eb71f405f.pdf",
            "news_date": "2023-11-10 12:59:21",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Announcement under Regulation 30 (LODR)-Investor Call Audio Recording",
            "news_id": "b6da737d-1118-4c46-b546-5acfa436058a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a0ecca0-1137-4e4e-b291-17c158d206d2.pdf",
            "news_date": "2023-11-06 21:04:13",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Investor Presentation",
            "news_id": "07683689-7b72-422c-8003-c5b546a8ab0b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cb5f432-19fc-476b-a7d3-1a385bf9b15c.pdf",
            "news_date": "2023-11-06 15:13:44",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited (Standalone & Consolidated) Financial Results For The Period  Ended September 30, 2023",
            "news_body": "Approval of Unaudited (Standalone & Consolidated) Financial Results for the period ended September 30, 2023",
            "news_id": "59916408-2eb4-4d2c-800b-d9721bfe342e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7217162-0c27-4d41-b2b3-06632199ff92.pdf",
            "news_date": "2023-11-04 18:58:12",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Transcript of Earning Call for quarter ended June 30, 2023.",
            "news_id": "fa96c488-a43b-4664-ad42-69d872242dc4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19cf69fa-8f5d-4883-ac5a-45efa85e6df4.pdf",
            "news_date": "2023-08-21 15:29:55",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Investor Call",
            "news_id": "d0b20b1b-2662-4f73-8821-0e869d51c765",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b3ca8ea-39fb-423a-b1b6-9c6efb8d3e1c.pdf",
            "news_date": "2023-08-14 18:44:41",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "07f7eec1-450b-43ee-8f72-116ae55813ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ae43f24-f270-4faf-8a3b-e9dfd8a5d1ea.pdf",
            "news_date": "2023-08-14 15:23:52",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Transcript of the Investor call",
            "news_id": "be4cf52a-9ee9-4157-8ca2-b082fa413c27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=309f1f21-faef-4672-8785-d4255f678a54.pdf",
            "news_date": "2023-05-18 17:26:28",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Outcome/Audio Recording of the Investor Call",
            "news_id": "337a319d-689a-44ec-9395-95e5630ecbdd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb69f3a1-680e-4bc3-a88f-25d34418803e.pdf",
            "news_date": "2023-05-11 17:50:16",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome - Audited Financial Results For Period Ended March 31, 2023",
            "news_body": "Board Meeting outcome - Audited Financial Results for period ended March 31, 2023",
            "news_id": "2fb6664b-0ccd-4503-a18e-aecb7228add2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15a10a89-e9d2-4927-bb25-e13a4fdbd5e6.pdf",
            "news_date": "2023-05-10 22:11:57",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Investor call/earning call held on February 17, 2023.",
            "news_id": "82b8ef86-0f54-40df-ac46-6f82e8471c42",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df98fc38-6909-4c21-a8da-6fc6a553bab1.pdf",
            "news_date": "2023-02-22 16:16:30",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approved Un-Audited Financial Results (Standalone & Consolidated) For Quarter Ended December 31, 2022.",
            "news_body": "Approved Un-Audited Financial Results (Standalone & Consolidated) for quarter ended December 31, 2022.",
            "news_id": "97f5fb02-651d-4c30-9ff8-c52911c8f330",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13afc985-843c-4905-aec9-5ad9c23b6fd3.pdf",
            "news_date": "2023-02-09 18:34:04",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Analyst/Investor Meetings of the Company",
            "news_id": "80658f29-9fa1-478a-8b4a-ef958a0b926f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1ac8f1e-43b9-4224-9823-264f64336d7e.pdf",
            "news_date": "2022-12-15 15:00:55",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Disclosure under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "6634aa16-f0bc-401d-bb25-e3fab3518632",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=609fa197-e1c0-4111-9d9f-3f738180ec6e.pdf",
            "news_date": "2022-11-28 18:57:29",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Orchid Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call",
            "news_id": "9cab6b19-cadf-4f22-96bf-227d327cfab3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=244a778e-64dd-40d5-8e88-5e6ee60486f5.pdf",
            "news_date": "2022-11-23 17:39:02",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Investor Call held on November 18, 2022.",
            "news_id": "7dc7a87b-4e89-4164-af9b-2779f072720a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=858e5d80-277d-476a-9d73-847f84372040.pdf",
            "news_date": "2022-11-18 18:24:05",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Un-Audited Financial Results Of The Company For Quarter And Half Year Ended Sept. 30, 2022.",
            "news_body": "Approval of the Un-Audited Financial results of the Company for quarter and half year ended Sept. 30, 2022.",
            "news_id": "712b6f01-3c14-4acc-be37-1e830eadf73f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85fb462c-e691-4852-bc78-b5e9b2a719af.pdf",
            "news_date": "2022-11-14 17:33:03",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analysts/Investors Conference Call pertaining to the Financial Results for the Quarter ended June 30, 2022",
            "news_id": "d11acf01-fee3-4f3e-8a75-26066d11d43c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0713971-a80a-42c3-9e6d-8d7a305f91f2.pdf",
            "news_date": "2022-08-17 18:19:22",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended June 30Th 2022",
            "news_body": "Un-Audited Financial Results for the Quarter ended June 30th 2022",
            "news_id": "50da52b8-b9fe-4a9e-bfc8-c921215f58b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae1c111b-8930-42f8-a734-d49122ccf144.pdf",
            "news_date": "2022-08-10 16:29:11",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation on Un-Audited Standalone & Consolidated Financial Results for the Quarter Ended 30 June, 2022",
            "news_id": "69297f68-2aad-4885-833f-09e34ab85570",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=020b984a-c33d-448e-984f-635e06e3ac80.pdf",
            "news_date": "2022-08-10 15:57:30",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "57c0b894-acc8-4b26-8355-c6052abf15db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a53ca327-0c79-4ede-9d81-cc3d79c80d34.pdf",
            "news_date": "2022-06-20 11:16:14",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Revised Outcome",
            "news_body": "Revised outcome - Audited financial results-March 31,2022-Legible format",
            "news_id": "9f77c31f-043d-49b0-9ed9-5078a4adec3a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d29ba818-5306-47f1-804a-06329d003d94.pdf",
            "news_date": "2022-05-17 19:35:01",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Financial Year Ended March 31,2022",
            "news_body": "Audited financial results for the financial year ended March 31,2022",
            "news_id": "0bc8e20c-e81f-417c-8d5e-67079730701d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c832321-8e74-4ee7-a305-9a99f093873b.pdf",
            "news_date": "2022-05-12 21:48:41",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting-May 12,2022",
            "news_body": "Outcome of Board meeting-May 12,2022-Approval of Audited financial results-March 31,2022",
            "news_id": "7515524c-bba9-4ed4-ba04-2d651ee8acc7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57b6246b-2e4e-4536-b8f5-f92e938ee4c3.pdf",
            "news_date": "2022-05-12 21:44:51",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings conference call (Q3FY2022) held on February 18, 2022",
            "news_id": "71f899c0-43c7-46f4-b187-54c86fc66074",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b72a45a4-6bd0-4c6d-ae41-983544d173c9.pdf",
            "news_date": "2022-02-24 20:21:52",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31,2021",
            "news_body": "Unaudited financial results for the quarter and nine months ended December 31,2021",
            "news_id": "f6979752-e074-401f-b388-9678172c995c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=670f4d71-eb1c-4fe8-a0ac-27a21919b832.pdf",
            "news_date": "2022-02-12 18:34:06",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 12,2022",
            "news_body": "Outcome of Board meeting held on February 12,2022",
            "news_id": "dab0d5cf-e12c-4050-9313-590225403dc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d69800a5-e90d-4d0f-8524-29f413dd5c4b.pdf",
            "news_date": "2022-02-12 18:28:44",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI(LODR) Regulations,2015- Investor presentation",
            "news_id": "4c39aaf8-70b7-48fa-9902-8e8b1c05f89d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf299d34-225b-4f36-8e3c-9cc490f0e8b0.pdf",
            "news_date": "2021-12-23 14:22:40",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on proposed Related Party Transactions",
            "news_id": "e5d654db-7502-46ee-95d5-5ae4f75ae8f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2b4e36f-9685-450b-b9a0-8012f306da98.pdf",
            "news_date": "2021-11-23 18:33:43",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30,2021",
            "news_body": "Unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30,2021",
            "news_id": "66d596e7-83f7-48be-a7b3-68e7cf461fb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a119570-b2f8-4354-b003-58694adda02d.pdf",
            "news_date": "2021-11-14 22:12:26",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Unaudited Financial Results (Standalone And<BR> Consolidated) For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Outcome of Board Meeting - Approval of Unaudited Financial Results (Standalone and<BR> Consolidated) for the Quarter and Half Year ended September 30, 2021",
            "news_id": "b51998ae-b2dc-4a5e-95f9-08a7afcfa320",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2233f8f-b953-4c90-a9cb-fcfbf2e69483.pdf",
            "news_date": "2021-11-14 22:05:03",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2021",
            "news_body": "Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2021",
            "news_id": "8807cb79-5bcd-45ca-b42f-678387401847",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6089ce3d-68ab-4e09-8e66-d1e11f721c31.pdf",
            "news_date": "2021-08-13 20:36:15",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Unaudited Financial Results (Standalone And Consolidated)<BR> For The Quarter Ended June 30, 2021",
            "news_body": "Outcome of Board Meeting - Approval of Unaudited Financial Results (Standalone and Consolidated)<BR> for the Quarter ended June 30, 2021",
            "news_id": "4517aa67-daf2-4a50-8eb2-f0787d08ca5e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e236aac-02d4-4e40-a7af-e9ab4f88eab7.pdf",
            "news_date": "2021-08-13 20:20:58",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015-Investor presentation",
            "news_id": "4cb0ac1c-a3c7-4e67-b48d-9955dacd0a98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd6f103a-349e-4563-9ac4-8d9170097677.pdf",
            "news_date": "2021-06-16 11:06:15",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015- Investor Presentation",
            "news_id": "1867e587-4c93-4b94-a082-b21563857102",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=292049f5-2c55-4478-96d4-3809ec567e1c.pdf",
            "news_date": "2021-06-09 13:50:47",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015-Investor Presentation",
            "news_id": "71b15374-c7fa-43d2-869d-00c9d3f4ad80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc25031a-9813-4060-84c9-12b205b97f2c.pdf",
            "news_date": "2021-06-09 10:51:00",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated ) For The Fourth Quarter And Financial Year Ended March 31,2021",
            "news_body": "Audited financial results (Standalone and Consolidated ) for the fourth quarter and financial year ended March 31,2021",
            "news_id": "0eac7c65-866c-40d9-b786-9a69961a6fc3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c32806c4-a3d8-4582-bee1-5f53ad92188b.pdf",
            "news_date": "2021-05-22 20:32:16",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}